MAPT and Mental deterioration: CSF p-Tau/Aβ40 therefore appears to increase sensitivity to detect tau-related neurodegeneration and cognitive decline compared to CSF p-Tau alone, particularly within the low, relatively restricted range of tau measurements observed in Aβ- individuals.